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Abstract 
Interspinous process devices are an 
alternative treatment of symptomatic 
lumbar spinal stenosis (LSS) to 
conventional surgery. Are presented various 
kinds of interspinous devices: X-STOP, 
IN-SPACE, SUPERION, APERIUS, 
ceramic spacers.  
Pathophysiology of lumbar spinal 
stenosis is presented together with 
biomechanics of interspinous implants 
which reduce loads on the facet joints, 
reduce pressure in the posterior annulus, 
increase foraminal and spinal canal 
dimensions. 
Indications, contraindications and 
precautions related to interspinous device 
surgery are presented. 
The results of in vitro studies are 
confirmed in randomized clinical trials. 
The improvements are statistically and 
clinically important, compared to those 
reported for laminectomy. 
Keywords: Lumbar spinal stenosis, 
interspinous devices. 
Introduction 
Lumbar spinal stenosis is one of the 
most common diseases in the elderly.  
Spinal stenosis is a narrowing of the 
spinal canal or neural foramina. Some 
patients are born with this narrowing, but 
most often spinal stenosis is the result of a 
degenerative condition with hypertrophy of 
the ligamentum flavum and facet joints, 
osteophytes, spondylolisthesis and disc 
protrusion. 
Symptoms of spinal stenosis constitute 
neurogenic claudication syndrome first 
described by Verbiest in 1954 [1]. 
Symptoms of pain or numbness in the legs 
are caused by lumbar spinal stenosis 
(47,4%) and by other diagnoses: diabetic 
neurophaty, peripheral artery disease [2]. 
Characteristics associated with lumbar 
spinal stenosis include age greater than 60, 
intermitent claudication, exacerbation of 
symptoms when standing up, improvement 
upon bending forward, absence of diabetes, 
good peripheral artery circulation. 
A positive straight leg raise test and 
symptoms induced with lumbar flexion are 
negatively correlated with the diagnosis of 
lumbar spinal stenosis. 
The lifetime risk has been estimated to 
be approximately 10% with a slight 
predominance of women.  
Some studies have documented that a 
large proportion of patients have stable 
symptoms for many years. 
Lumbar spinal stenosis is a progressive 
disabling condition which compromises an 
individual`s ability to perform their 
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activities of daily living, reduces quality of 
life and threatens one`s independence. 
Pathophysiology 
In 1954 Verbiest [1] published a series of 
7 case reports of patients with intermitent 
neurogenic claudication. In each case 
myelography showed a block in the lumbar 
region, which was confirmed at operation. 
In 1978 Kirkaldy-Willis [3] described 
the pathophysiology of lumbar spinal 
stenosis based on cadaveric dissections and 
patients’ laminectomy. LSS begins with 
repetitive minor trauma over many years. 
LSS is the result of destruction of the 
posterior joints causing synovial reaction, 
cartilage destruction, osteophyte formation 
and intervertebral disc disruption. 
These changes lead to loss of disc height, 
facet instability, buckling of the 
ligamentum flavum, narrowing of the 
neural foramina and spinal canal and 
impinging - each or all together - upon 
structures within them. This lead to 
chronic compression of the nerve roots 
causing decreased blood flow, ischemia and 
local edema. 
The load - bearing structures in each 
vertebra are the vertebral body and the two 
facets. 
Changes of lumbar facet joints are 
responsive of 15-40% of chronic low back 
pain. Facet specific back pain is exacerbated 
by hyperextension and lessened in a 
recumbent position or flexion. During 
extension, deformation of the joint capsule 
is the source of pain. The capsule 
surrounding the facet joint is innervated by 
afferent nociceptive fibers, which are 
activated by mechanical stresses. 
Increased facet loading is a consequence 
of disc degeneration. In the case of facet 
joint degeneration or removal, the motion 
segment is unstable, allowing greater sagital 
displacement and acceleration of disc 
degeneration. Long - term lumbar segment 
instability results in degenerative 
spondylolisthesis. 
Treatment of lumbar spinal stenosis 
In the past lumbar spinal stenosis had 
only a conservative treatment. 
Conservative treatment includes physical 
therapy, non-steroidal anti-inflammatory 
drugs, opioid analgesics, epidural steroid 
injections and lumbar corsets. 
Pain relief from epidural injection may 
be temporary and patients are usually 
advised to get no more than 3 injections per 
6 - month period. 
Physical therapy and / or exercises help 
stabilize the spine, build endurance and 
increase flexibility. 
While some patients obtain relief from 
symptoms with this "conservative" therapy, 
others do not. 
Patients often fail conservative therapy 
because these treatment options do not alter 
the anatomic pathology that causes 
symptoms, do not enlarge the spinal canal 
or foramina. When conservative 
management fails is indicated surgical 
intervention in the form of mechanical 
decompression of the posterior spinal 
elements. 
The conventional surgical treatment for 
spinal stenosis is a lumbar laminectomy. 
Wide decompressive laminectomy has been 
the standard procedure, though recently 
less invasive surgical approaches have been 
tried. Gibson [4] in a systematic review of 
recent studies suggests that laminectomy 
alone had better results than laminectomy 
associated with instrumented or non-
instrumented fusion. The author concluded 
that there was no clear evidence regarding 
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the most effective technique for surgical 
decompression of spinal stenosis. 
Studies have been unable to identify 
patient characteristic that predict who is 
likely to respond best to surgery and who 
will respond to conservative management 
[5]. 
The study of Weinstein et all [6] 
suggests that surgical management of 
degenerative lumbar spinal stenosis 
achieves better than nonsurgical care. 
However, major surgery, an invasive 
surgical treatment, especially can lead to 
complications, therapy, miminimally 
invasive surgery is an important option for 
elderly patients who tend to present with 
comorbidities and other health risks. 
As a result, interspinous process 
distraction with different spacers has been 
used widely over the past years. 
Devices 
The first interspinous implant for the 
lumbar spine was developed in the 1950s by 
Knowles (cited by Kondrashov, 2006). 
Owing to flaws in design, material, surgical 
technique and applied indications its use 
was abandoned. Technological advances, 
which have contributed to improved safety 
and efficacy, have rekindled an interest in 
IPD implantation. Now exist various kinds 
of interspinous devices: 
1. The X-STOP Interspinous Process 
Decompression (IPD) (St. Francis Medical 
Technologies, Concord System CA) is the 
first alternative to conventional spinal 
stenosis surgery proven to significantly 
improve symptom severity and physical 
function. 
The X-STOP device is a titanium metal 
implant designed to fit between spinous 
processes of the vertebrae (Figure 1). It is 
designed to remain safely and permanently 
in place without attaching to the bone or 
ligaments. It is MRI safe but can produce 
artifacts on MR image. 
 
 
 
 
 
Figure 1 X-STOP implant 
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X-STOP IPD is available in Europe 
since 2002 and received FDA approval in 
2005. X-STOP is currently the only IPD 
device available in the United States. 
2. The IN - SPACE Interspinous spacer 
(Synthes USA, LLC) is another 
percutaneous minimally invasive device 
which put the stenotic segment in slight 
flexion, enlarge the spinal canal and 
foramen (Figure 2). 
Senegas [7] found positive long - term 
results with the first ISS, which was 
implanted in 1986. 
3. In Japan, since 2002 is used a new 
distraction device (Pentax Co, Tokyo, 
Japan) made of hydroxy-apatite and calcium 
phosphate. His shape is cylindrical and on 
the surface of the midportion it harbors 
grooves (Figure 3)[8]. 
 
 
Figure 2 IN - SPACE Interspinous spacer 
 
 
Figure 3 Ceramic spacers 
4. The SUPERION Interspinous Spacer 
(ISS) (VertiFeex, CA, USA) (Figure 4) is an 
device composed of titanium alloy, and 
consists of a single component with 
deployable superior and inferior projections 
that engage the spinous processes to secure 
it is opened, thus providing distraction at 
the affected spinal segment. 
SUPERION has been CE marked since 
2007 and is currently an investigational 
device in the U.S. It is the most advanced 
and least invasive spacer and allows for the 
procedure to be done local anesthesia on an 
outpatient basis. 
5. APERIUS PercLID System (Figure 5) 
can be used at any level between L1 and L5 
[9]. 
 
 
A 
 
B 
Figure 4 SUPERION Implant: device (A) and 
intraoperative fluoroscopic image (B) 
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Figure 5 APERIUS PercLID System: device (A) and 
postoperative spine radiographs (B) 
Biomechanics of interspinous spacers 
Biomechanical results reported by 
Panjabi et all [10], anatomic results 
reported by Inufusa et all [11] and clinical 
results reported by Fredericson [12] et all 
have shown that when individuals shift 
their spine from an extended position, the 
cross-sectional foraminal area increases and 
nerve root compression is relieved. 
An interspinous spacer is designed to 
hold the stenotic level in flexion. 
An interspinous spacer produce an 
unloading of the stenotic middle column of 
the spine, which is evident as an increase in 
foraminal height, related to increased 
foraminal area and decreased canal stenosis. 
Lazaro et all [13] observed that 
foraminal height, after the ISS was inserted, 
decreased during extension with 1.4% 
compared with 4.7% decreased without ISS. 
Foraminal area is with 4.2% larger during 
extension after ISS implantation. With ISS 
facet loads were reduced by more than 50% 
during full extension. 
Richards et all [14] found that foraminal 
area increased by 25% during extension 
after X-STOP implantation. 
Lee et all [15] reported that the mean 
dural sac area increased by 23% after X-
STOP placement and intervertebral 
foraminal area improved by 36%. 
Siddiqui et all [16] found that the spinal 
cross section examination with MRI, the 
mean canal dimension increased 20% in 
standing patients, and 27% in extension 
with X-STOP implantation. 
Wiseman et all [17] showed that the 
mean pressure of the facet joint was 
reduced by 39% at the X-STOP implanted 
level. 
Chiu [18] reported that X-STOP 
unloads posterior annulus pressure by 63%, 
posterior nucleus pulposus pressure by 41% 
and facet force by 68%. 
These in vitro studies of interspinous 
spaces have shown increased foraminal and 
spinal canal dimensions at the implanted 
level in extension, a reduction of the 
pressure in the posterior annulus in 
extension and off-loading of the facet joints 
without altering the dimensions or 
pressures in the adjacent non-operated 
levels. Thus, these spaces may prevent the 
development of disorders at there levels. 
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Indications for use of interspinous 
devices 
All kind of interspinous implants are 
indicated for the treatment of patients aged 
50 or older, suffering from pain or 
intermitent neurogenic claudication in the 
legs secondary to a confirmed diagnosis of 
central and/or lateral process lumbar spinal 
stenosis and not responding to at least 6 
month of non-operative treatment. 
These patients have to have lumbar 
stenotic symptoms of moderate severity 
with pain relief in flexed lumbar - and 
exacerbation when in an extended position. 
Other indication for interspinous 
implants are contained HNP, 
spondylolisthesis up to 35% (grade 1.5/4) 
with intermitent neurogenic claudication, 
facet syndrome, degenerative and/or 
iatrogenic (post-discectomy) disc 
syndrome, Baastrup`s syndrome (Kissing 
spine) and for unloading of disc adjacent to 
a lumbar fusion procedure. 
Interspinous devices can be implanted at 
one or two lumbar levels. 
Contraindications of interspinous 
devices 
These devices are contraindicated in 
patients with:  
•an allergy to titanium or titanium alloy 
•spinal anatomy or disease that would 
prevent implantation of the device or cause 
the device to be unstable in the body: 
- significant instability of the lumbar 
spine 
- acute fracture of the spinous process or 
pars interarticularis 
- significant scoliosis (Cobb angle 
greater than 25 degrees) 
- an ankylosed segment at the affected 
level 
•cauda equina syndrome 
•severe osteoporosis in the spine, 
defined as bone mineral density more than 
2,5 SD below the mean of adult normal. 
•active systemic infection or infection 
localized to the site of implantation 
Precautions 
Implantation of interspinous devices can 
be an effective treatment option, but it is 
not a panacea for all patients with 
degenerative lumbar spine conditions. 
The interspinous device does not replace 
microsurgical decompression in patients 
with massive stenosis and continuous 
claudication. To avoid the postoperative 
complications of X-STOP interspinous 
distractor, not only the clinical indications 
deserve attention, but also the patient’s 
lumbar anatomic characteristics. 
Barbagallo et all [19] scrutinized these 
characteristics and proposed a novel 
anatomic scoring system to classify the 
patient’s anatomic features and to make a 
good patient selection, for this 
decompression procedure (Table 1). 
 
TABLE 1 
Anatomic scoring system according to Barbagallo 
Score Inferior SP morphology Accessible SP length Interspinous area shape 
1 Concave Entire SP length Parallel 
2 Straight Posterior 2/3 of the SP Posterior V shape 
3 Convex / Dysmorphic Posterior 1/3 of the SP ---- 
SP - spinous process. 
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There are 17 possible combinations in 
the scoring system: 
- a score of 3-4, suitable conditions for 
placement of an interspinous device 
- a score of 5-6, risk conditions 
- a score of 7-8, potential 
contraindications. 
A V-shaped posterior interspinous area is 
a risk factor for device dislocation, and a 
potential contraindication. A parallel 
interspace is a more suitable anatomic 
finding. 
The issues analyzed by Barbagallo et all 
have to thoroughly considerent among the 
inclusion / exclusion criteria before surgery, 
to obtain a high success rate. 
Insertion of an interspinous devices is 
not without risk. 
The potential adverse events of 
interspinous implants are: implant 
dislodgement / migration, fracture of the 
spinous process, foreign body reaction, 
mechanical failure of the device, additional 
surgery with removal of the implant. 
The anatomic improvements 
demonstrated in prior cadaveric studies 
were confirmed in vivo, in randomized 
clinical trials [8, 20, 21, 22, 23]. 
The outcomes were strongly in favor of 
interspinous devices when compared to 
those reported for laminectomy. The 
improvements were statistically and 
clinically important. 
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